Part D/Prescription Drugs

Pharma Fights Back

Jim Greenwood, chief executive officer of the Biotechnology Innovation Organization, said at a recent convention held in San Francisco, “our industry has become an easy scapegoat for the real and growing problem of patient access to affordable new medications …my friends, we are fighting back.” Read article here….

Notice: The link provided above connects readers to the full content of the posted article. The URL (internet address) for this link is valid on the posted date; medicarereport.org cannot guarantee the duration of the link’s validity. Also, the opinions expressed in these postings are the viewpoints of the original source and are not explicitly endorsed by AMAC, Inc.; the AMAC Foundation, Inc.; or medicarereport.org.